MELI vs. NOVO-B.CO
MELI (MercadoLibre, Inc.) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. MELI operates in Internet Retail (Consumer Cyclical), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 10 years, MELI returned 28.09%/yr vs 17.63%/yr for NOVO-B.CO. At a 0.16 correlation, their price movements are largely independent.
Performance
MELI vs. NOVO-B.CO - Performance Comparison
Loading charts...
Different Trading Currencies
MELI is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, MELI achieves a -21.08% return, which is significantly lower than NOVO-B.CO's -10.15% return. Over the past 10 years, MELI has outperformed NOVO-B.CO with an annualized return of 28.09%, while NOVO-B.CO has yielded a comparatively lower 17.63% annualized return.
MELI
- 1D
- -1.27%
- 1M
- -1.11%
- YTD
- -21.08%
- 6M
- -21.15%
- 1Y
- -32.98%
- 3Y*
- 9.54%
- 5Y*
- 2.68%
- 10Y*
- 28.09%
NOVO-B.CO
- 1D
- 1.53%
- 1M
- -5.28%
- YTD
- -10.15%
- 6M
- -8.95%
- 1Y
- -41.84%
- 3Y*
- 6.83%
- 5Y*
- 19.41%
- 10Y*
- 17.63%
MELI vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MELI MercadoLibre, Inc. | -21.08% | 18.46% | 8.20% | 85.71% | -37.24% | -19.51% | 192.90% | 95.30% | -6.93% | 101.99% |
NOVO-B.CO Novo Nordisk A/S | -10.15% | -39.54% | -15.04% | 214.95% | 23.90% | 65.39% | 27.16% | 32.88% | -10.64% | 58.82% |
Correlation
The correlation between MELI and NOVO-B.CO is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Sep 7, 2007 | 0.16 |
The correlation between MELI and NOVO-B.CO shifts across timeframes, from 0.06 (1 year) to 0.16 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MELI vs. NOVO-B.CO — Risk / Return Rank
MELI
NOVO-B.CO
MELI vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MercadoLibre, Inc. (MELI) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MELI | NOVO-B.CO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.07 | ||
| Sortino ratioReturn per unit of downside risk | -0.14 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 0.88 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | -0.81 | -0.79 | -0.02 |
| Martin ratioReturn relative to average drawdown | -1.42 | -1.17 | -0.24 |
Loading charts...
Drawdowns
MELI vs. NOVO-B.CO - Drawdown Comparison
The maximum MELI drawdown since its inception was -89.49%, which is greater than NOVO-B.CO's maximum drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for MELI and NOVO-B.CO.
Loading charts...
Drawdown Indicators
| MELI | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.49% | -74.86% | -14.63% |
Max Drawdown (1Y)Largest decline over 1 year | -40.82% | -54.48% | +13.66% |
Max Drawdown (3Y)Largest decline over 3 years | -40.82% | -74.86% | +34.04% |
Max Drawdown (5Y)Largest decline over 5 years | -68.64% | -74.86% | +6.22% |
Max Drawdown (10Y)Largest decline over 10 years | -69.12% | -74.86% | +5.74% |
Current DrawdownCurrent decline from peak | -39.18% | -67.88% | +28.70% |
Average DrawdownAverage peak-to-trough decline | -23.58% | -12.38% | -11.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.24% | 36.72% | -13.48% |
Volatility
MELI vs. NOVO-B.CO - Volatility Comparison
The current volatility for MercadoLibre, Inc. (MELI) is 9.96%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 12.08%. This indicates that MELI experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MELI | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.96% | 12.08% | -2.12% |
Volatility (6M)Calculated over the trailing 6-month period | 29.79% | 40.71% | -10.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.48% | 55.70% | -16.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.65% | 58.93% | -9.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.88% | 45.48% | +3.40% |
Dividends
MELI vs. NOVO-B.CO - Dividend Comparison
MELI has not paid dividends to shareholders, while NOVO-B.CO's dividend yield for the trailing twelve months is around 4.07%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MELI MercadoLibre, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.19% | 0.38% | 0.36% |
NOVO-B.CO Novo Nordisk A/S | 4.07% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
Financials
MELI vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between MercadoLibre, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MELI and NOVO-B.CO have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for MELI and NOVO-B.CO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer